Evidence map›Paper›PMID 24391818›Full record

ArticlePloS one2013

Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk.

Evangelina López de Maturana, Yuanqing Ye, M Luz Calle, Nathaniel Rothman, Víctor Urrea, Manolis Kogevinas, Sandra Petrus, Stephen J Chanock, Adonina Tardón, Montserrat García-Closas and 9 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Statin-Associated Hepatotoxicity Linked toYonsei medical journal · 2026
    Article
  2. Effect of smoking on the recurrence and progression of non-muscle-invasive bladder cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Inflammatory-Related Genetic Variants in Non-Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 2 countries.

Evangelina López de MaturanaGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Yuanqing YeDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
M Luz CalleSystems Biology Department, University of Vic, Vic, Spain.
Nathaniel RothmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America.
Víctor UrreaSystems Biology Department, University of Vic, Vic, Spain.
Manolis KogevinasCentre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain ; Institut Municipal d'Investigació Mèdica - Hospital del Mar, Barcelona, Spain.
Sandra PetrusGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain ; Systems Biology Department, University of Vic, Vic, Spain.
Stephen J ChanockDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America.
Adonina TardónUniversidad de Oviedo, Oviedo, Spain.
Montserrat García-ClosasDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America.
Anna González-NeiraGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Gemma VellaltaInstitut Municipal d'Investigació Mèdica - Hospital del Mar, Barcelona, Spain.
Alfredo CarratoHospital Universitario de Elche, Elche, Spain ; Hospital Universitario Ramon y Cajal, Madrid, Spain.
Arcadi NavarroDepartament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain ; Institut de Biologia Evolutiva (UPF-CSIC), Barcelona, Spain ; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain ; Instituto Nacional de Bioinformática, Barcelona, Spain.
Belén Lorente-GaldósDepartament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain ; Institut de Biologia Evolutiva (UPF-CSIC), Barcelona, Spain ; Instituto Nacional de Bioinformática, Barcelona, Spain.
Debra T SilvermanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America.
Francisco X RealGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain ; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
Xifeng WuDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Núria MalatsGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
National Cancer Institute · USSpanish National Cancer Research Centre · ESCentro de Investigación del Cáncer · ESThe University of Texas MD Anderson Cancer Center · USUniversitat de Vic - Universitat Central de Catalunya · ESCenter for Research in Environmental Epidemiology · ESHospital Del Mar · ESHospital General Universitario de Elche · ESInstitut de Biologia Evolutiva · ESPompeu Fabra University · ESUniversidad de Oviedo · ES

Funding

Targeting Ral GTPases in Bladder CancerP50CA091846 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DINNEY, COLIN P.N., MCCONKEY, DAVID J. · 2001 to 2018
$37.4M
Genome-Wide Association Analysis of Bladder CancerU01CA127615 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WU, XIFENG · 2008 to 2012
$5.1M
PHARMACOGENETICS OF DRUG &CARCINOGEN METABOLISMR01CA034627 · NCI · UNIVERSITY OF NORTH DAKOTA · PI HEIN, DAVID W · 1985 to 2009
$3.1M
GENETIC MARKERS OF BLADDER CANCER PROGRESSIONR01CA089715 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALBERTSON, DONNA G · 2001 to 2012
$3.1M
Markers of Genetic Susceptibility to Bladder CancerR01CA074880 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WU, XIFENG · 1999 to 2008
$3.1M
Telomere length, telomere maintenance gene polymorphisms, and bladder cancer riskR01CA131335 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GU, JIAN · 2008 to 2011
$1.3M
NCI NIH HHS CA34627NCI NIH HHS P50 CA091846NCI NIH HHS P50 CA 91846NCI NIH HHS R01 CA034627NCI NIH HHS R01 CA074880NCI NIH HHS R01 CA089715NCI NIH HHS R01- CA089715NCI NIH HHS R01 CA 131335NCI NIH HHS R01 CA131335NCI NIH HHS R01 CA 74880NCI NIH HHS U01 CA 127615NCI NIH HHS U01 CA127615
6 · The paper itself

Abstract

The relationship between inflammation and cancer is well established in several tumor types, including bladder cancer. We performed an association study between 886 inflammatory-gene variants and bladder cancer risk in 1,047 cases and 988 controls from the Spanish Bladder Cancer (SBC)/EPICURO Study. A preliminary exploration with the widely used univariate logistic regression approach did not identify any significant SNP after correcting for multiple testing. We further applied two more comprehensive methods to capture the complexity of bladder cancer genetic susceptibility: Bayesian Threshold LASSO (BTL), a regularized regression method, and AUC-Random Forest, a machine-learning algorithm. Both approaches explore the joint effect of markers. BTL analysis identified a signature of 37 SNPs in 34 genes showing an association with bladder cancer. AUC-RF detected an optimal predictive subset of 56 SNPs. 13 SNPs were identified by both methods in the total population. Using resources from the Texas Bladder Cancer study we were able to replicate 30% of the SNPs assessed. The associations between inflammatory SNPs and bladder cancer were reexamined among non-smokers to eliminate the effect of tobacco, one of the strongest and most prevalent environmental risk factor for this tumor. A 9 SNP-signature was detected by BTL. Here we report, for the first time, a set of SNP in inflammatory genes jointly associated with bladder cancer risk. These results highlight the importance of the complex structure of genetic susceptibility associated with cancer risk.

Indexed as

Bayes TheoremAdultAgedAged, 80 and overAlgorithmsArtificial IntelligenceBiomarkers, TumorCase-Control StudiesFemaleFollow-Up StudiesGenetic Predisposition to DiseaseHumansInflammationInflammation MediatorsMaleMiddle AgedBiomarkers, TumorInflammation Mediators

Identifiers

PMID24391818
PMCPMC3877090
OpenAlexW2079774874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.